Common Equity: The sum of all common equity items.
Assembly Biosciences, Inc. (ASMB) had Common Equity of $206.75M for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
$72.30M |
|
$-6.12M |
|
-- |
|
$72.30M |
|
$84.42M |
|
$-12.12M |
|
$6.00M |
|
$-6.12M |
|
$-6.12M |
|
$-6.12M |
|
$-6.12M |
|
$-6.12M |
|
$-6.12M |
|
$-12.12M |
|
$-14.34M |
|
11.21M |
|
11.21M |
|
$-0.55 |
|
$-0.55 |
|
| Balance Sheet Financials | |
$254.55M |
|
$0.22M |
|
$3.04M |
|
$257.59M |
|
$48.78M |
|
-- |
|
$2.06M |
|
$50.84M |
|
|
Common Equity |
$206.75M |
$206.75M |
|
$206.75M |
|
15.86M |
|
| Cash Flow Statement Financials | |
$-41.09M |
|
$-113.47M |
|
$174.67M |
|
$38.34M |
|
$58.45M |
|
$20.11M |
|
$4.68M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
5.22 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-16.76% |
|
-16.76% |
|
-19.83% |
|
-8.47% |
|
-8.47% |
|
$-41.16M |
|
-- |
|
-- |
|
-- |
|
0.28 |
|
-- |
|
74.23 |
|
4.92 |
|
-2.96% |
|
-2.96% |
|
-2.38% |
|
-2.96% |
|
$13.04 |
|
$-3.67 |
|
$-3.67 |
|